Information Technology · Services-Computer Processing & Data Preparation

IBEX IBEX Ltd SEC Filings & Insider Trading Activity 2026

company
CIK 1720420123 filings
Russell 2000

IBEX at a glance

IBEX Ltd (IBEX, SEC CIK 1720420) filed its latest 10-K annual report on September 10, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as November 17, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended June 30, 2026 (FY2026), IBEX Ltd (IBEX) reported revenue of $644.1 million (up 15.4% from FY2025) and net income of $46.3 million. Diluted EPS was $3.13.
  • As of September 30, 2026, 25 institutional investment managers tracked by SignalX reported holding IBEX Ltd (IBEX) shares worth $213.2 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Afdahl David Martin on November 16, 2026 of 28,319 shares at $56.35 per share.
  • In the last 90 days, IBEX insiders reported 0 open-market purchases ($0) and 19 open-market sales ($7.2M) on Form 4, a net sale of $7.2M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2026
$644.1M
+15.4% vs prior year
Insiders · 90 days
0 buys · 19 sells
Net −$7.2M
13F holders
25 funds
$213.2M · −2 vs prior quarter
Latest 8-K
Nov 5, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Jun 30, 2026

Full analysis →

Risk Factors

  • Regulatory risk: compliance with evolving global data privacy laws including FTC, EU, UK rules impacting processing, security of personal data
  • Geopolitical risk: heavy dependency on Philippines, Jamaica, Pakistan, Nicaragua with exposure to political instability, natural disasters, frequent power outages
  • Operational risk: reliance on third-party telecom, data providers and vulnerability to system failures, cyberattacks, and electricity outages in near-shore regions
  • Competitive risk: AI-driven automation reducing demand for standardized services and challenge from competitors with advanced technology and scale
  • Financial risk: customer concentration with top three clients accounting for 24% of revenue, top client 9%, risking material impact from client loss or contract termination

Management Discussion & Analysis

  • Revenue $644.1M, up 15.4% YoY (+$85.8M), driven by HealthTech +38.5% (+$31.7M), Retail & E-commerce +14.1% (+$20.5M), Travel & Logistics +17.2% (+$13.3M)
  • Net income $46.3M (+25.7%) with margin 7.2% vs 6.6% prior year; adjusted EBITDA margin 12.8% vs 12.9% prior year; operating margin 8.5% vs 8.3%
  • Best performing segment HealthTech revenue +38.5% to 17.7% of total; worst Telecommunications segment revenue down 18.7% to 9.2% of total
  • Operating cash flow $59.0M (+29.2%); capex $27.8M (+51.3%), focused on offshore expansions and IT; share repurchases $14.4M with $20M buyback authorized
  • Management highlights leveraging AI innovations, offshore delivery optimization, and expects FY27 capex $25-30M; risks include wage inflation, macroeconomic uncertainty, and currency impacts

Business Overview

  • Core business: technology-enabled customer lifecycle experience (CLX) solutions including BPO, AI-powered customer engagement, digital marketing, and acquisition technology
  • New emphasis: AI-led CX platform Wave iX with AI Virtual Agent and AI-powered real-time translation enhancing AI-human hybrid service model
  • Strategic shift: reposition from traditional BPO to digital-first, AI-driven BPO 3.0 focusing on tech, culture, and integrated omni-channel delivery
  • Workforce growth: 35,000 employees as of June 30, 2026, up 2,000 from prior year, with 97% capacity offshore/nearshore
  • Notable: eNPS of 82 and client NPS of 71, reflecting top-tier employee engagement and client satisfaction in a largely commoditized industry

AI summary of the IBEX 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Revenue $175.2M, up 15.9% YoY from $151.2M, led by HealthTech growth of $8.7M, or 39.9%
  • Operating margin 10.4% vs 9.1% YoY, net income margin 8.4% vs 8.0%, adjusted EBITDA margin 14.4% vs 12.9%
  • Worst-performing vertical: FinTech revenue down $0.3M, or 1.7% YoY
  • Operating cash flow $16.3M vs $15.7M, capital expenditures $7.2M, free cash flow $9.2M vs $8.0M
  • Emerging headwinds: wage pressure, inflation, labor shortages, client shifts toward lower-priced offshore delivery, evolving AI regulation and adoption

Risk Factors

  • No material changes to Annual Report risk factors
  • Carried-forward financial risk: adverse effects on financial position, results, or cash flows
  • Unknown or currently immaterial risks could materially harm operations

AI summary of the IBEX 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 5, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • IBEX reported fiscal Q1 2026 results for the quarter ended September 30, 2026
  • Detailed revenue, earnings and guidance information appears in Exhibit 99.1, the attached earnings release

Item EX-99.1: Item EX-99.1

  • Q1 FY2027 revenue $175.2M, up 15.9%, extending double-digit organic growth to seven consecutive quarters
  • Adjusted EBITDA $25.2M, up 29.4%, with margin expanding to 14.4% from 12.9%
Filed Sep 10, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • FY2026 revenue $644.1M, up 15.4%, with HealthTech up 38.5% and Technology up 25.6%
  • FY2026 diluted EPS $3.13, up 32.8%, while adjusted EPS reached $3.52, up 28.3%

Item 2.02: Results of Operations and Financial Condition

  • IBEX reported fourth-quarter and fiscal-year results for the period ended June 30, 2026
  • Exhibit 99.1 contains the press release with the financial results and management commentary

Item 2.03: Creation of a Direct Financial Obligation

  • Item 2.03 creates a direct financial obligation through the material agreement described under Item 1.01
  • Investor impact depends on Item 1.01 terms, including obligation amount, interest rate, maturity and purpose

Item 1.01: Entry into a Material Definitive Agreement

  • U.S. and UAE credit maturities extended to October 22, 2029, improving near-term refinancing flexibility
  • U.S. facility: $25 million secured revolver with 0.20% closing fee and 0.30% annual fee on unused capacity
Filed May 13, 2026Full analysis →

Item 8.01: Other Events

  • Board-authorized repurchases of up to $20 million in common stock beginning May 14, 2026
  • One-year authorization, with purchases through open-market, private, block-trade, or other permitted transactions

AI summaries of IBEX 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for IBEX

Don't miss the next IBEX filing

  • Alerts as it files. A push when IBEX files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut IBEX, by share count.
  • Ask anything. An AI agent that reads every IBEX filing and answers with sources.

IBEX alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Afdahl David MartinMNov 16, 2026$12.75
Afdahl David MartinSellNov 16, 2026$56.35
Afdahl David MartinMNov 16, 2026-
Afdahl David MartinMNov 16, 2026-
Afdahl David MartinMNov 16, 2026$19.00
Casteel Julie KSellNov 13, 2026$56.70
Ringman MichaelFNov 11, 2026$55.32
McGinnis PatrickSellNov 10, 2026$50.48

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2024FY2025FY2026
Profitability
Revenue-$558.3M$644.1M
Operating Income-$46.6M$55.0M
Net Income$33.7M$36.9M$46.3M
Op. Margin-8.3%8.5%
Net Margin-6.6%7.2%
Balance Sheet
Total Assets$293.9M$273.2M$309.1M
Equity-$134.3M$170.2M
ROE-27.4%27.2%
Per Share
EPS$1.84$2.36$3.13
Cash Flow
Operating CF-$45.7M$59.0M
CapEx$8.9M$18.4M$27.8M

Source: XBRL data in IBEX Ltd (IBEX)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate IBEX share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
IBEX shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202625$213.2M
Q2 202627$143.3M
Q1 202627$113.5M
Q4 202525$144.9M
Q3 202526$173.9M
Q2 202527$108.2M
Q1 202523$76.1M
Q4 202418$37.7M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 198 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

IBEX filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 17, 2026--
4Nov 17, 2026--
4Nov 12, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
4Nov 10, 2026--
8-KNov 5, 2026Analysis-
10-QNov 5, 2026Analysis
4Nov 3, 2026--
4Nov 3, 2026--
4Nov 3, 2026--
4Nov 3, 2026--
4Nov 3, 2026--
4Nov 3, 2026--
4Nov 3, 2026--
4Nov 3, 2026--
4Nov 3, 2026--
4Oct 7, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--

Related Information Technology companies

All Information Technology →

IBEX SEC filings: frequently asked questions

Are IBEX insiders buying or selling?

In the last 90 days, IBEX Ltd (IBEX) officers, directors and 10% owners reported no open-market purchases and 19 open-market sales worth $7.2 million by 9 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold IBEX stock?

As of September 30, 2026, the largest IBEX Ltd (IBEX) holders among the 13F filers tracked by SignalX were BlackRock ($43.3 million), Vanguard Capital Management LLC ($17.9 million), Dimensional Fund Advisors ($17.3 million), Two Sigma Investments ($17.1 million), Ameriprise Financial ($16.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was IBEX's revenue in fiscal year 2026?

For the fiscal year ended June 30, 2026 (FY2026), IBEX Ltd (IBEX) reported revenue of $644.1 million (up 15.4% from FY2025) and net income of $46.3 million. Diluted EPS was $3.13. The figures come from the XBRL data in the 10-K.

What are the main risks in IBEX's latest 10-K?

In the 10-K filed September 10, 2026, IBEX Ltd (IBEX) flagged: Regulatory risk: compliance with evolving global data privacy laws including FTC, EU, UK rules impacting processing, security of personal data. Geopolitical risk: heavy dependency on Philippines, Jamaica, Pakistan, Nicaragua with exposure to political instability, natural disasters, frequent power outages. (AI summary of the Risk Factors section.)

What did IBEX report in its latest 8-K?

IBEX Ltd (IBEX) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). IBEX reported fiscal Q1 2026 results for the quarter ended September 30, 2026.

What are the latest IBEX SEC filings?

IBEX Ltd (IBEX) filed its latest 10-K annual report on September 10, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on November 17, 2026.

What is IBEX's SEC CIK number?

IBEX Ltd (IBEX)'s SEC Central Index Key (CIK) is 1720420. EDGAR lists every IBEX filing under that number.

Ask anything about IBEX

The research agent reads IBEX's filings, financials, insider trades and 13F holders, then answers with sources.